Infarmed Reads SNS Medicine Spend at a Record €4.417 Billion in 2025 — Hospital Drugs Cross €2.5 Billion for the First Time as Oncology Adds €864.5 Million at +16% and Ambulatory Comparticipação Lifts to €1.894 Billion at +12.4%
Infarmed's 2025 monitor puts SNS medicine spending at a record €4,417M — +60% above the 2020 baseline. Hospitals carry €2,523M (+11.2%), ambulatory €1,894M (+12.4%), families €966M (+4.9%). Oncology adds €864.5M (+16%), orphan drugs +34.1%, and Q1 2026 hospitals already +7.6%.